RECRUITING Not applicable ClinicalTrials.gov

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Sponsor: Medtronic - MITG • ClinicalTrials.gov ID: NCT07351071

Registry updated: 2026-09-01

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The purpose of this study is to evaluate the safety and performance of the Signia™ power handle, Signia™ circular adapter, and Signia™ Tri-Staple™ 2.0 circular reloads (hereafter referred to as Signia™ circular stapler) in patients undergoing left sided colon, sigmoid, or rectal resections in a post market setting.

Interventions

Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system) (Device)
Signia™ Circular Stapling system used for the creation of an anastomosis

Eligibility criteria

Preoperative Inclusion Criteria: 1. Subject is competent and willing to provide documented informed consent to participate in this clinical study 2. Subject is intended to undergo an elective left sided colon/colorectal procedure where a creation of an anastomosis will be completed with the Signia™ circular stapler 3. Subject is ≥ 18 years of age at time of consent Preoperative Exclusion Criteria: 1. Subject is unable or unwilling to comply with the study requirements or follow-up schedule 2. Subject with ASA classification ≥ IV 3. Subject is pregnant (as determined by standard site practices) 4. The procedure is an emergency procedure 5. The procedure is a revision/reoperation for the same indication 6. The subject has a documented confounding medical condition which in the opinion of the investigator, will not be appropriate for the study, or the subject has an estimated life expectancy of less than 6 months 7. Subject has participated or plans to participate in an investigational drug or device research study that would interfere with the results of this study 8. Subject will undergo multiple synchronous colon resections 9. Subject with a bleeding disorder or is undergoing anticoagulant treatment that has not been reversed (anticoagulant prophylaxis prescribed as part of the surgical protocol is allowed) 10. Subject has undergone chemotherapy or received biologics within 6 weeks prior to the day of the procedure 11. Subject has history of chronic corticosteroid use (used greater than 3 months within a year prior to the index procedure) 12. Subject has chronic immunosuppression therapy (used greater than 3 months within a year prior to the index procedure) 13. Any subject undergoing an ileal-anal pouch anastomosis surgery Intraoperative Exclusion Criteria 1. Anastomosis not attempted with the Signia™ circular stapler 2. Any subject for which the device is intended to be used outside the instructions for use (IFU)

Conditions

Colorectal Anastomosis Left-sided Colon Resection Anastomotic Leak Anastomotic Complication Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Postoperative Complications Anastomotic Leaks

Locations

Yale University — New Haven, Connecticut, United States
The University of South Florida — Tampa, Florida, United States
Wellstar Hospital — Marietta, Georgia, United States
Massachusetts General Hospital — Boston, Massachusetts, United States
Mayo Clinic — Rochester, Minnesota, United States
Duke University — Durham, North Carolina, United States
The Ohio State University Wexner Medical Center — Columbus, Ohio, United States
Lankenau Institute for Medical Research — Wynnewood, Pennsylvania, United States
University of Texas Health Science Center at Houston — Houston, Texas, United States
SSM Health St. Mary's Hospital - Madison — Madison, Wisconsin, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment